Body dysmorphic disorder: An overview;Body dysmorphic disorder (stoornis in de lichaamsbeleving): Een overzicht

Tijdschrift voor Psychiatrie

Volumn 47, Issue 1, 2005, Pages 21-27

  Vulink, N C C ^a,b,c   Denys, D ^a,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Opleiding Tot Klin Onderzoeker   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Body dysmorphic disorder; Dysmorphobia; Somatoform disorders

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ARTICLE; BEHAVIOR THERAPY; BODY DYSMORPHIC DISORDER; CLINICAL TRIAL; COGNITIVE THERAPY; DERMATOLOGY; DOPAMINERGIC SYSTEM; EARLY DIAGNOSIS; HUMAN; MEDICAL LITERATURE; MEDLINE; PHOBIA; PLASTIC SURGERY; PREVALENCE; PSYCHIATRIC TREATMENT; PSYCINFO; SEROTONINERGIC SYSTEM; SOMATOFORM DISORDER;

EID: 12344265666     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Albertini, R.S., & Phillips, K.A. (1999). Thirty-three cases of body dysmorphic disorder in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 453-459.
2. Altamura, C., Paluello, M.M., Mundo, E., e.a. (2001). Clinical and subclinical body dysmorphic disorder. European Archives of Psychiatry and Clinical Neuroscience, 251, 105-108.
3. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (4de versie). Washington, DC: American Psychiatric Press.
4. Andreasen, N.C., & Bardach, J. (1977). Dysmorphophobia: symptom or disease? American Journal of Psychiatry, 134, 673-676.
5. Barr, L.C., Goodman, W.K., & Price, L.H. (1992). Acute exacerbation of body dysmorphic disorder during tryptophan depletion. American Journal of Psychiatry, 149, 1406-1407.
6. Biby, E.L (1998). The relationship between body dysmorphic disorder and depression, self-esteem, somatization, and obsessive-compulsive disorder. Journal of Clinical Psychology, 54, 489-499.
7. Bienvenu, O.J., Samuels, J.F., Riddle, M.A., e.a. (2000). The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biological Psychiatry, 48, 287-293.
8. Bohne, A., Wilhelm, S., Keuthen, N.J., e.a. (2002). Prevalence of body dysmorphic disorder in a German college student sample. Psychiatry Research, 109, 101-104.
9. Bouman, T.K. (1998). Spiegeltje, spiegeltje aan de wand... Cognitieve gedragstherapie en de stoornis in de lichaamsbeleving (Body Dysmorphic Disorder). Gedragstherapie, 31, 205-219.
10. Brawman-Mintzer, O., Lydiard, R.B., Phillips, K.A., e.a. (1995). Body dysmorphic disorder in patients with anxiety disorders and major depression: a comorbidity study. American Journal of Psychiatry, 152, 1665-1667.
11. Cororve, M.B., & Cleaves, D.H. (2001). Body dysmorphic disorder: a review of conceptualizations, assessment, and treatment strategies. Clinical Psychology Review, 21, 949-970.
12. Cotterill, J.A., & Cunliffe, W.J. (1997). Suicide in dermatological patients. The British Journal of Dermatology, 137, 246-250.
13. Craven, J.L., & Rodin, G.M. (1987). Cyproheptadine dependence associated with an atypical somatoform disorder. Canadian Journal of Psychiatry, 32, 143-145.
14. Dufresne, R.G., Phillips, K.A., Vittorio, C.C., e.a. (2001). A screening questionnaire for body dysmorphic disorder in a cosmetic dermatologic surgery practice. Dermatologic Surgery, 27, 457-462.
15. Faravelli, C., Salvatori, S., Galassi, F., e.a. (1997). Epidemiology of somatoform disorders: a community survey in Florence. Social Psychiatry and Psychiatric Epidemiology, 32, 24-29.
16. Fawcett, R.G. (2002). Olanzapine for the treatment of monosymptomatic hypochondriacal psychosis. Journal of Clinical Psychiatry, 63, 169.
17. Fitts, S.N., Gibson, P., Redding, C.A., e.a. (1989). Body dysmorphic disorder: implications for its validity as a DSM-III-R clinical syndrome. Psychological Reports, 64, 655-658.
18. Grant, J.E., Kim, S.W., & Crow, S.J. (2001). Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients. Journal of Clinical Psychiatry, 62, 517-522.
19. Hollander, E., Allen, A., Kwon, J., e.a. (1999). Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Archives of General Psychiatry, 56, 1033-1039.
20. Hollander, E., Cohen, L., Simeon, D., e.a. (1994). Fluvoxamine treatment of body dysmorphic disorder. Journal of Clinical Psychopharmacology, 14, 75-77.
21. Hollander, E., Liebowitz, M.R., Winchel, R., e.a. (1989). Treatment of body-dysmorphic disorder with serotonin reuptake blockers. American Journal of Psychiatry, 146, 768-770.
22. Hollander, E., Neville, D., Frenkel, M., e.a. (1992). Body dysmorphic disorder. Diagnostic issues and related disorders. Psychosomatics, 33, 156-165.
23. Ishigooka, J., Iwao, M., Suzuki, M., e.a. (1998). Demographic features of patients seeking cosmetic surgery. Psychiatry and Clinical Neurosciences, 52, 283-287.
24. Jerome, L. (2001). Dysmorphophobia and taphephobia: two hitherto undescribed forms of insanity with fixed ideas (E. Morselli, Vert.). History of Psychiatry, 45, 103-114.
25. Koot, V.C., Peeters, P.H., Granath, F., e.a. (2003). Total and cause specific mortality among Swedish women with cosmetic breast implants: prospective study. British Medical Journal, 326, 527-528.
26. Lochner, C., & Stein, D.J. (2001). Gender in obsessive-compulsive disorder and obsessive-compulsive spectrum disorders. Archives of Women's Mental Health, 4, 19-26.
27. Marks, I., & Mishan, J. (1988). Dysmorphophobic avoidance with disturbed bodily perception. A pilot study of exposure therapy. British Journal of Psychiatry, 152, 674-678.
28. Neziroglu, F., & Yaryura-Tobias, J.A. (1997). A review of cognitive behavioral and pharmacological treatment of body dysmorphic disorder. Behavior Modification, 21, 324-340.
29. Otto, M.W., Wilhelm, S., Cohen, L.S., e.a. (2001). Prevalence of body dysmorphic disorder in a community sample of women. American Journal of Psychiatry, 158, 2061-2063.
30. Perugi, G., Giannotti, D., Di Vaio, S., e.a. (1996). Fluvoxamine in the treatment of body dysmorphic disorder (dysmorphophobia). International Clinical Psychopharmacology, 11, 247-254.
31. Phillips, K.A. (1991). Body dysmorphic disorder: the distress of imagined ugliness. American Journal of Psychiatry, 148, 1138-1149.
32. Phillips, K.A. (1996). An open study of buspirone augmentation of serotonin-reuptake inhibitors in body dysmorphic disorder. Psychopharmacology Bulletin, 32, 175-180.
33. Phillips, K.A., Albertini, R.S., & Rasmussen, S.A. (2002). A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Archives of General Psychiatry, 59, 381-388.
34. Phillips, K.A., Albertini, R.S., Siniscalchi, J.M., e.a. (2001b). Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study. Journal of Clinical Psychiatry, 62, 721-727.
35. Phillips, K.A., & Diaz, S.F. (1997). Gender differences in body dysmorphic disorder. The Journal of Nervous and Mental Disease, 185, 570-577.
36. Phillips, K.A., Dufresne, R.G., Jr., Wilkel, C.S., e.a. (2000). Rate of body dysmorphic disorder in dermatology patients. Journal of the American Academy of Dermatology, 42, 436-441.
37. Phillips, K.A., Grant, J., Siniscalchi, J., e.a. (2001b). Surgical and nonpsychiatric medical treatment of patients with body dysmorphic disorder. Psychosomatics, 42, 504-510.
38. Phillips, K.A., McElroy, S.L., Keck, P.E., Jr., e.a. (1993). Body dysmorphic disorder: 30 cases of imagined ugliness. American Journal of Psychiatry, 150, 302-308.
39. Phillips, K.A., McElroy, S.L., Keck, P.E., Jr., e.a. (1994). A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacology Bulletin, 30, 1751-186.
40. Phillips, K.A., & Najjar, F. (2003). An open-label study of citalopram in body dysmorphic disorder. Jounal of Clinical Psychiatry, 64, 715-720.
41. Rauch, S.L., Phillips, K.A., Segal, E., e.a. (2003). A preliminary morphometric magnetic resonance imaging study of regional brain volumes in body dysmorphic disorder. Psychiatric Research, 122, 13-19.
42. Rosen, J.C., Reiter, J., & Orosan, P. (1995). Cognitive-behavioral body image therapy for body dysmorphic disorder. Journal of Consulting and Clinical Psychology, 63, 263-269.
43. Sarwer, D.B., Wadden, TA., Pertschuk, M.J., e.a. (1998). Body image dissatisfaction and body dysmorphic disorder in 100 cosmetic surgery patients. Plastic and Reconstructive Surgery, 101, 1644-1649.
44. Simeon, D., Hollander, E., Stein, D.J., e.a. (1995). Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder. American Journal of Psychiatry, 152, 1207-1209.
45. Spitzer, R.L., Williams, J.B., Gibbon, M., e.a. (1992). The Structured Clinical Interview for DSM-III-R (SCID). I:History, rationale, and description. Archives of General Psychiatry, 49, 624-629.
46. Veale, D. (2002). Over-valued ideas: a conceptual analysis. Behaviour Research and Therapy, 40, 383-400.
47. Veale, D., Boocock, A., Gournay, K., e.a. (1996a). Body dysmorphic disorder. A survey of fifty cases. British Journal of Psychiatry, 169, 196-201.
48. Veale, D., Ennis, M., & Lambrou, C. (2002). Possible association of body dysmorphic disorder with an occupation or education in art and design. American Journal of Psychiatry, 159, 1788-1790.
49. Veale, D., Gournay, K., Dryden, W., e.a. (1996a). Body dysmorphic disorder: a cognitive behavioural model and pilot randomised controlled trial. Behaviour Research and Therapy, 34, 717-729.
50. Vindigni, V., Pavan, C., Semenzin, M., e.a. (2002). The importance of recognizing body dysmorphic disorder in cosmetic surgery patients: do our patients need a preoperative psychiatric evaluation? Presented at the 13th Annual Meeting of European Association of Plastic Surgeon (ERAPS), Crete, Greece.
51. Wilhelm, S., Otto, M.W., Lohr, B., e.a. (1999). Cognitive behavior group therapy for body dysmorphic disorder: a case series. Behaviour Research and Therapy, 37, 71-75.